RT Journal Article
SR Electronic
T1 Predicting appropriateness of antibiotic treatment among ICU patients with hospital acquired infection
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.08.15.23294109
DO 10.1101/2023.08.15.23294109
A1 Rannon, Ella
A1 Goldschmidt, Ella
A1 Bernstein, Daniel
A1 Wasserman, Asaf
A1 Coster, Dan
A1 Shamir, Ron
YR 2023
UL http://medrxiv.org/content/early/2023/08/16/2023.08.15.23294109.abstract
AB Antimicrobial resistance is a growing threat to global health, leading to ineffective treatment of infection and increasing treatment failure, mortality, and healthcare costs. Inappropriate antibiotic therapy is often administered in the Intensive Care Unit (ICU) due to the urgency of treatment, but can lead to poor patient outcomes. In this study, we developed a machine learning model that predicts the appropriateness of antibiotic treatments for ICU inpatients with ICU-acquired blood infection. We analyzed data from electronic medical records (EMRs), including demographics, administered drugs, previous microbiological cultures, invasive procedures, lab measurements and vital signs. Since EMRs have high rates of missing values and since our cohort is relatively small and imbalanced, we introduced novel computational methods to address these issues. The final model achieved an AUROC of 82.8% and an AUPR of 60.6% on the training set and an AUROC score of 77.3% and an AUPR score of 40.4% on the validation set. Our study shows the potential of machine learning models for inappropriate antibiotic treatment prediction.Competing Interest StatementThe authors have declared no competing interest.Funding StatementStudy supported in part by the Israel Science Foundation (grant No. 3165/19, within the Israel Precision Medicine Partnership program, and grant No. 2206/22) and by the Tel Aviv University Center for AI and Data Science (TAD). EG, ER and DC are supported in part by fellowships from the Edmond J. Safra Center for Bioinformatics at Tel-Aviv University.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The MIMIC-III database analyzed in this study is available on the PhysioNet repository. This is a restricted-access resource. To access the files, we had to fulfill all of the following requirements: be a credentialed user finish required training and sign the data use agreement for the project.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes